PMID:37841449 | PMC:PMC10568337 | DOI:10.1016/j.ijcrp.2023.200218
PubMed articles on: Cardio-Oncology
J Pathol. 2023 Oct 16. doi: 10.1002/path.6212. Online ahead of print.
ABSTRACT Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical application is limited due to it...
No comments:
Post a Comment
اكتب تعليق حول الموضوع